PARP1 and cancer: Among these synthesized compounds, 5l exhibited the most potent inhibitory effects on PARP-1 (16.10 ± 1.25 nM) enzyme and MDA-MB-436 (11.62 ± 2.15 μM) cancer cell, which were just a little weaker than Olaparib.